A newly filed motion in the Ninth Circuit, No. 3 Motion to Dismiss in case 26-5041, puts a familiar but consequential appellate issue front and center: whether the appeal should proceed at all. Appellees Joseph Taylor, Mick Cleary, Jennifer [as listed on the docket], and others filed the motion on August 7, 2026, asking the court to terminate the appeal at the threshold rather than reach the merits.

At this stage, a motion to dismiss in the court of appeals typically targets a defect in appellate jurisdiction or a serious procedural flaw.

Tuesday’s legal news cycle delivered a familiar but important message for practitioners: the biggest developments are no longer confined to blockbuster merits rulings. Instead, the day’s most significant events cut across enforcement priorities, regulatory implementation, procedural positioning, and the increasingly fast-moving intersection of agencies, courts, and corporate decision-making.

For litigators, that matters because legal risk is now being shaped as much by timing, forum, and government posture as by black-letter doctrine.

Meta Platforms, Inc. has launched a new inter partes review proceeding at the Patent Trial and Appeal Board in IPR2026-00420, filed on August 7, 2026.

A federal judge in Washington, D.C. has approved the SEC’s settlement with Elon Musk over allegations that he failed to timely disclose his early purchases of Twitter stock, but not without an unusually pointed warning. U.S. District Judge Sparkle Sooknanan signed off on the deal while stating she had “significant misgivings” and saw potential “red flags” in the resolution.

The settlement requires a trust in Musk’s name to pay $1.5 million and resolves claims tied to delayed beneficial ownership disclosures.

The Federal Trade Commission has announced what it calls a major antitrust settlement with Caremark, resolving a closely watched case against one of the country’s largest pharmacy benefit managers. Even without the full settlement details in hand, the development is important: it signals that the FTC is continuing to press competition theories aimed at the role PBMs play in drug pricing, formulary design, and pharmacy reimbursement.

For antitrust and healthcare lawyers, the significance goes well beyond a single company.

The U.S. Court of Appeals for the Second Circuit has handed federal prosecutors a significant win in the Buffalo mass-shooting case, ruling that the Justice Department may rely on the alleged gunman’s racist motive as part of its pursuit of the death penalty. The decision addresses a high-stakes issue in one of the most closely watched federal criminal prosecutions in the country: how the government may frame aggravating factors when seeking capital punishment.

At a practical level, the ruling means prosecutors can present the alleged racial animus behind the 2022 supermarket attack as relevant to the penalty phase, rather than being forced to cabin the case to the underlying acts alone.

Luxottica of America Inc. has filed a new inter partes review proceeding at the Patent Trial and Appeal Board, opening another matter for practitioners tracking how major consumer-brand companies use PTAB challenges as part of broader patent defense strategy. The petition, docketed as IPR2026-00412 and filed on August 7, 2026, is now pending before the Board.

At this early stage, the PTAB docket entry identifies Luxottica of America Inc. in the case caption, but the publicly available case summary does not yet provide the full set of details practitioners will want to monitor closely, including the challenged patent number, the named patent owner, and the specific prior-art grounds asserted in the petition.

The Federal Trade Commission has inserted itself into a debate with potentially long-term consequences for the legal profession: who gets to decide whether a lawyer’s education is good enough for bar admission. In a recent endorsement of an Ohio Supreme Court proposal, the FTC supported reducing the American Bar Association’s outsized role in determining whether a law school credential qualifies an applicant to sit for the bar.

That is more than an academic governance issue.

In a brief opinion filed August 3, 2026, the U.S. Court of Appeals for the Second Circuit affirmed the district court’s judgment in docket No. 25-1162.

Weill Cornell Medicine has reached a settlement with Manhattan federal prosecutors to resolve a criminal investigation into allegations that the institution failed for years to prevent a physician’s sexual abuse of patients. The matter, handled by the U.S. Attorney’s Office for the Southern District of New York, is notable not only because of the underlying misconduct allegations, but because prosecutors trained their focus on the institution’s response — or lack of response — to warning signs and complaints.

That distinction matters.

The Third Circuit’s August 5, 2026 opinion in No. 25-3032 is now available, but practitioners should note an immediate limitation for analysis: the public case information provided here identifies the court, docket number, and filing date, but does not include the text of the opinion itself. That means any substantive assessment of the panel’s holding, its reasoning, or its precedential effect depends on reviewing the opinion directly.

For lawyers tracking developments in the Third Circuit, that distinction matters.

The U.S. Department of Justice Antitrust Division has announced that it is resuming a more targeted Hart-Scott-Rodino merger review process, an important procedural shift for companies navigating premerger notification in 2026. Although this is not a court filing or enforcement complaint, it is still a meaningful legal development: it tells dealmakers and their counsel how one of the government’s primary antitrust enforcers intends to allocate resources and frame early-stage merger scrutiny.

At a practical level, a “targeted” review approach suggests the Division is moving away from a broader, more expansive initial review posture and returning to a process more closely tailored to transactions that present identifiable competitive risks.

The Justice Department’s proposed settlement with Willow Bridge Property Company LLC marks another important step in the government’s expanding antitrust challenge to rent-setting tools and shared market data in multifamily housing. The case, filed in the U.S. District Court for the Middle District of North Carolina, fits into a broader enforcement push targeting allegations that landlords used common pricing software and competitively sensitive information to coordinate rents.

While the specific terms of the proposed resolution will matter, the headline takeaway is already clear: DOJ is not treating rental algorithms as a niche issue.

The Tenth Circuit’s August 4, 2026 order in appeal No. 26-6021 appears to be a procedural disposition rather than a published merits opinion, and that matters for how practitioners should read it.

The Justice Department said on August 6 that Duke University School of Law intentionally discriminated on the basis of race in admissions for its 2023, 2024, and 2025 entering classes, concluding that the school’s practices violated Title VI and the Supreme Court’s ban on race-based admissions in Students for Fair Admissions, Inc. v. President and Fellows of Harvard College et al.

The finding is significant not only because it targets a prominent law school, but because it shows continued federal enforcement activity after Students for Fair Admissions. That 2023 decision reshaped the legal framework for admissions nationwide, holding that the use of race in college admissions could not survive constitutional scrutiny.